Literature DB >> 27415609

Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.

Irina Kalatskaya1.   

Abstract

Esophageal adenocarcinoma (EAC) develops in the sequential transformation of normal epithelium into metaplastic epithelium, called Barrett's esophagus (BE), then to dysplasia, and finally cancer. BE is a common condition in which normal stratified squamous epithelium of the esophagus is replaced with an intestine-like columnar epithelium, and it is the most prominent risk factor for EAC. This review aims to impartially systemize the knowledge from a large number of publications that describe the molecular and biochemical alterations occurring over this progression sequence. In order to provide an unbiased extraction of the knowledge from the literature, a text-mining methodology was used to select genes that are involved in the BE progression, with the top candidate genes found to be TP53, CDKN2A, CTNNB1, CDH1, GPX3, and NOX5. In addition, sample frequencies across analyzed patient cohorts at each stage of disease progression are summarized. All six genes are altered in the majority of EAC patients, and accumulation of alterations correlates well with the sequential progression of BE to cancer, indicating that the text-mining method is a valid approach for gene prioritization. This review discusses how, besides being cancer drivers, these genes are functionally interconnected and might collectively be considered a central hub of BE progression.
© 2016 New York Academy of Sciences.

Entities:  

Keywords:  Barrett's esophagus; cancer progression; esophageal adenocarcinoma; genomic alterations

Mesh:

Substances:

Year:  2016        PMID: 27415609     DOI: 10.1111/nyas.13134

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 2.  Pathology of esophageal cancer and Barrett's esophagus.

Authors:  Shilpa Jain; Sadhna Dhingra
Journal:  Ann Cardiothorac Surg       Date:  2017-03

3.  Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.

Authors:  Yongchen Guo; Yonghua Bao; Ming Ma; Shanshan Zhang; Yongmeng Zhang; Ming Yuan; Bing Liu; Yiqiong Yang; Wen Cui; Emmanuel Ansong; Huali Dong; Virgilia Macias; Wancai Yang
Journal:  Oncotarget       Date:  2017-05-16

4.  Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.

Authors:  David S Liu; Sanne J M Hoefnagel; Oliver M Fisher; Kausilia K Krishnadath; Karen G Montgomery; Rita A Busuttil; Andrew J Colebatch; Matthew Read; Cuong P Duong; Wayne A Phillips; Nicholas J Clemons
Journal:  Oncotarget       Date:  2016-12-13

Review 5.  Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2017-09-14

6.  Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis.

Authors:  Feng He; Bo Ai; Lei Tian
Journal:  Biomed Rep       Date:  2018-07-25

Review 7.  NOX5: Molecular biology and pathophysiology.

Authors:  Rhian M Touyz; Aikaterini Anagnostopoulou; Francisco Rios; Augusto C Montezano; Livia L Camargo
Journal:  Exp Physiol       Date:  2019-03-18       Impact factor: 2.969

Review 8.  The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers.

Authors:  Nathalia Meireles Da Costa; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti; Antonio Palumbo
Journal:  Biomed Res Int       Date:  2019-10-13       Impact factor: 3.411

Review 9.  A narrative review of Barrett's esophagus in 2020, molecular and clinical update.

Authors:  Aamir N Dam; Jason Klapman
Journal:  Ann Transl Med       Date:  2020-09

10.  NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors.

Authors:  Smitha Antony; Guojian Jiang; Yongzhong Wu; Jennifer L Meitzler; Hala R Makhlouf; Diana C Haines; Donna Butcher; Dave S Hoon; Jiuping Ji; Yiping Zhang; Agnes Juhasz; Jiamo Lu; Han Liu; Iris Dahan; Mariam Konate; Krishnendu K Roy; James H Doroshow
Journal:  Mol Carcinog       Date:  2017-08-30       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.